Roszczyk E, Goodgal S
J Bacteriol. 1975 Jul;123(1):287-93. doi: 10.1128/jb.123.1.287-293.1975.
Specific methylases that have the properties of deoxyribonucleic acid (DNA) modification enzymes have been isolated from Haemophilus influenzae strain Rd. Two activities ((Methylase IIa and methylase III) were found to protect transforming DNA of H. parainfluenzae from the action of H. influenzae restriction enzymes. To determine the specificty of the protection, a procedure based on biological activity was developed for the separation and purification of the restriction endonucleases from H. influenzae strain Rd. Two endonuclease R activities presumably corresponding to Hind II and Hind III (P. H. Roy and H. O. Smith, 1973; H. O. Smith and K. W. Wilcox, 1970) were characterized by differences in their chromatographic properties, ability to attack T7 DNA, and inactivation of the transforming activity of different markers of H. parainfluenzae DNA. One endonuclease R enzyme (Hind II) attacked T7 DNA and was found to inactivate the dalacin resistance marker (smaller than 0.01% activity remaining) with only a slight effect on the streptomycin resistance marker (83% activity remaining). Methylase IIa treatment protected 40% of the dalacin resistance marker of H. parainfluenzae DNA from inactivation by Hind II. The other restriction activity (Hind III) was inert towards T7 DNA and inactivated the streptomycin resistance marker of H. parainfluenzae DNA (smaller than 0.01% activity remaining) without any effect on the dalacin resistance marker. The methylation of H. parainfluenzae DNA accomplished by methylase III protected 60% of the transforming activity of the streptomycin resistance marker of H. parainfluenzae DNA from the action of Hind III.
已从流感嗜血杆菌Rd菌株中分离出具有脱氧核糖核酸(DNA)修饰酶特性的特定甲基化酶。发现两种活性(甲基化酶IIa和甲基化酶III)可保护副流感嗜血杆菌的转化DNA免受流感嗜血杆菌限制酶的作用。为了确定保护的特异性,开发了一种基于生物活性的方法,用于从流感嗜血杆菌Rd菌株中分离和纯化限制性内切酶。两种内切酶R活性可能分别对应于Hind II和Hind III(P. H. Roy和H. O. Smith,1973;H. O. Smith和K. W. Wilcox,1970),通过它们的色谱特性、攻击T7 DNA的能力以及使副流感嗜血杆菌DNA不同标记的转化活性失活的情况来表征。一种内切酶R酶(Hind II)攻击T7 DNA,发现它能使对达托霉素耐药的标记失活(剩余活性小于0.01%),而对链霉素耐药标记的影响很小(剩余活性83%)。甲基化酶IIa处理可保护副流感嗜血杆菌DNA中40%的达托霉素耐药标记不被Hind II失活。另一种限制活性(Hind III)对T7 DNA无作用,可使副流感嗜血杆菌DNA的链霉素耐药标记失活(剩余活性小于0.01%),而对达托霉素耐药标记无任何影响。由甲基化酶III完成的副流感嗜血杆菌DNA甲基化可保护副流感嗜血杆菌DNA链霉素耐药标记60%的转化活性免受Hind III的作用。